MYOS RENS Technology (MYOS) Rockets On Merger With MedAvail To Penetrate Muscle Health Market

Many businesses dream of penetrating whole markets as their stakeholders usually prefer expansion through a merger or acquisition. Hence, most of the giants lead industries and dictate market prices.

Just yesterday NASDAQ: MYOS was $0.88 with little change in daily trading volume. After the merger with MedAvail, MYOS RENS Technology’s stock becomes attractive to new investors so its daily volume soars to more than 127 million shares.

Penny MYOS could shortly be hot stock and slow rise may occur with an indication of stability in long term growth.

Related:  Naked Brand Group Limited (NASDAQ: NAKD) Surges To Cross $1 Barrier

The muscle health market is getting larger while weight loss is still trending as eating in fast food courts and restaurants leads to obesity. MYOS RENS Technology chose the right market which has a high potential in growth.

Asan Abdiev

CEO and Editor in Chief. Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life